Calithera Biosciences (CALA) Key Ratios
$0.00
As on 02-Sep-2026 16:00EDT
Market cap
$0 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
0.1
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | 22.88 | 89.38 | 63.53 | 15.66 | -9.99 |
| Net Profit | 29.24 | 94.22 | 87.73 | 21.04 | 4.87 |
| EPS | 29.28 | 95.55 | 88.38 | 23.17 | 11.13 |
| Book Value | -- | -- | 87.48 | -56.74 | -45.17 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -1,180.39 | -718.89 | -- | -1,180.39 | -- |
| Net Margin
| -7,081.84 | -4,963.42 | -- | -- | -7,081.84 |
| Return on equity
| -137.09 | -102.52 | -131.13 | -207.83 | -72.32 |
| Return on Capital
| -87.27 | -72.25 | -50.86 | -142.78 | -68.17 |
| Return on Assets
| -73.82 | -61.52 | -40.38 | -120.93 | -60.15 |
| Debt to Equity (x)
| -- | -- | 0.08 | 5.22 | 0.07 |
Profitability
ROCE
-50.86
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-50.86
|
-142.78
|
-68.17
|
-62.27
|
-37.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-131.13
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-131.13
|
-207.83
|
-72.32
|
-64.16
|
-37.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-40.38
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-40.38
|
-120.93
|
-60.15
|
-55.44
|
-30.71
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
--
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
-1,180.39
|
--
|
--
|
-257.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
--
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
-1,180.39
|
-7,081.84
|
-2,845.01
|
-231.29
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-1.00
--
Year on year growth in net sales
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-1.00
|
--
|
--
|
-1.00
|
-0.14
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
65.55
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
65.55
|
-25.93
|
1.62
|
-62.17
|
-92.96
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
83.61
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
83.61
|
-30.01
|
-2.52
|
-67.75
|
-84.98
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
0.87
--
Year on year growth in earnings per share
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.87
|
-0.22
|
0.20
|
-0.17
|
-0.72
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.08
--
Total debt / Net worth
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.08
|
5.22
|
0.07
|
0.06
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.08
--
(Short term borrowings / Net worth)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.08
|
0.16
|
0.02
|
0.01
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
3.60
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
3.60
|
4.39
|
6.45
|
8.14
|
9.42
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
--
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
--
|
6.53
|
8.17
|
9.56
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-1.91
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-1.91
|
-333.59
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
--
|
--
|
--
|
8.97
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
0.10
|
--
|
--
|
0.13
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
28.86
|
--
|
--
|
25.76
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
-392.50
|
-197.57
|
-5.93
|
-67.20
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
577.81
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
577.81
|
718.78
|
395.13
|
7.90
|
6.40
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
--
|
-1,082.42
|
--
|
--
|
-47.84
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
-0.84
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
-0.84
|
-0.02
|
-0.20
|
-0.18
|
-0.15
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
0.78
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.78
|
0.30
|
0.17
|
0.11
|
0.06
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
0.21
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
Calithera Biosciences (CALA)
|
0.21
|
0.12
|
1.00
|
1.44
|
2.26
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|